SCHEMBL24813335

SCHEMBL24813335

c1ccc(-c2c3ccccc3c(-c3ccc4ccccc4c3)c3cc(-c4ccc(-c5cncc(-c6ccc7c(-c8ccc(-c9ccc%10ccccc%10c9)cc8)c8ccc(-c9ccc(-c%10ccccn%10)cc9)cc8c(-c8ccc(-c9ccc%10ccccc%10c9)cc8)c7c6)c5)cc4)ccc23)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 4/20 0.44
CYP11B2 P19099 4/20 0.44
CYP19A1 P11511 2/20 0.44
CYP17A1 P05093 1/20 0.44
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
LMNA P02545 2/20 0.40
TP53 P04637 2/20 0.40
MAPT P10636 2/20 0.40
PKM P14618 2/20 0.40
TSHR P16473 2/20 0.40
KLF5 Q13887 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HSD17B10 Q99714 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CYP2A6 P11509 1/20 0.40
DHODH Q02127 2/20 0.39
DCTPP1 Q9H773 1/20 0.37
SIRT2 Q8IXJ6 3/20 0.37
CYP1A1 P04798 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13016100 0.91 KDM4E (0.45) CYP11B1CYP11B2CYP19A1CYP17A1KDM4E
SCHEMBL13015754 0.91 CYP11B1 (0.47) CYP11B1CYP11B2CYP19A1CYP17A1KDM4E
SCHEMBL15977771 0.89 SMN1; SMN2 (0.48) CYP11B1CYP11B2CYP19A1CYP17A1KDM4E
SCHEMBL15977931 0.89 SMN1; SMN2 (0.48) CYP11B1CYP11B2CYP19A1CYP17A1KDM4E
SCHEMBL10030057 0.88 SMN1; SMN2 (0.49) CYP11B1CYP11B2CYP19A1CYP17A1KDM4E
SCHEMBL15977760 0.88 CYP11B1 (0.55) CYP11B1CYP11B2CYP19A1CYP17A1KDM4E
SCHEMBL15977553 0.88 CYP11B1 (0.55) CYP11B1CYP11B2CYP19A1CYP17A1KDM4E
SCHEMBL10030067 0.87 SIRT2 (0.47) CYP11B1CYP11B2CYP19A1CYP17A1KDM4E
SCHEMBL13016150 0.87 KDM4E (0.48) CYP11B1CYP11B2CYP19A1CYP17A1KDM4E
SCHEMBL275959 0.87 SMN1; SMN2 (0.48) CYP19A1KDM4EALDH1A1LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 CYP11B1 1241/4885CYP11B2 1585/4885CYP19A1 936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.